Wockhardt Metoprolol Succinate Extended-Release Tablets — Class II drug recall D-1541-2014
Terminated recall by Wockhardt Usa Inc., reported 2014-08-27, distributed nationwide. Failed Dissolution Specifications: Dissolution failures found during testing of control samples at the four ho
| Recall number | D-1541-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Wockhardt Usa Inc., Parsippany, NJ, United States |
| Recall initiated | 2014-07-24 |
| Classified | 2014-08-18 |
| Reported by FDA | 2014-08-27 |
| Terminated | 2015-11-20 |
| Distributed | Nationwide (US) |
| Quantity | 11,661 hdpe |
| Reason classes | specification failure |
| NDC | 64679-0737-02, 64679-0737-03 |
Product
Wockhardt Metoprolol Succinate Extended-Release Tablets, USP 200 mg, a) 100-count bottle (NDC 64679-737-02), b) 500-count bottle (NDC 64679-737-03) Rx only, Manufactured by: Wockhardt Limited Mumbai, India Distributed by: Wockhardt USA LLC 20 Waterview Boulevard. Parsippany, NJ 07054 USA
Reason for recall
Failed Dissolution Specifications: Dissolution failures found during testing of control samples at the four hour time point.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1541-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.